VATS Instruments Market: $1.34B to $2.43B by 2034, 6.8% CAGR
Video-Assisted Thoracic Surgery (VATS) Instruments
VATS Instruments Market: $1.34B to $2.43B by 2034, 6.8% CAGR
Video-Assisted Thoracic Surgery (VATS) Instruments by Type (Forceps, Scissors, Clamps, Needle Holders, Other), by Application (Hospital, Clinic, Other), by North America (United States, Canada, Mexico), by South America (Brazil, Argentina, Rest of South America), by Europe (United Kingdom, Germany, France, Italy, Spain, Russia, Benelux, Nordics, Rest of Europe), by Middle East & Africa (Turkey, Israel, GCC, North Africa, South Africa, Rest of Middle East & Africa), by Asia Pacific (China, India, Japan, South Korea, ASEAN, Oceania, Rest of Asia Pacific) Forecast 2026-2034
Updated On : Sep 1, 2026|Base Year : 2025|Pages : 120
Amit Mardhekar
Research Analyst
About Sector Data Insights
Sector Data Insights (SDI) is a specialized market intelligence and strategic consulting firm focused on delivering high-quality, data-driven syndicated research reports, industry analysis, competitive intelligence, and advisory solutions. With a strong emphasis on analytical excellence, particularly in life sciences, analytical instrumentation, and related high-tech sectors, Sector Data Insights empowers manufacturers, investors, service providers, researchers, and decision-makers with actionable insights for strategic growth, innovation, and market leadership.
SDI combines deep domain expertise in laboratory and analytical technologies with advanced analytics to provide comprehensive market assessments, technology trend analysis, vendor share data, investment intelligence, supply chain insights, and forward-looking forecasts. Our research supports organizations navigating complex global markets across industries such as life sciences, semiconductors & electronics, consumer goods, materials & chemicals, construction & manufacturing, food & beverages, energy & power, automotive & transportation, ICT & media, aerospace & defense, and BFSI.
The global Video-Assisted Thoracic Surgery (VATS) Instruments Market is positioned for consistent expansion, with a base-year valuation of $1.34 billion in 2025 and a 6.8% CAGR that is projected to lift the market to approximately $2.43 billion by 2034. Growth is anchored in the continuing transition from open thoracotomy to minimally invasive thoracic procedures, a shift accelerated by advances in endoscopic imaging, instrument articulation, and surgeon training. VATS procedures account for more than half of all lung resections in North America and Europe, creating stable demand for specialized forceps, scissors, clamps, and needle holders.
Video-Assisted Thoracic Surgery (VATS) Instruments Market Size (In Billion)
2.0B
1.5B
1.0B
500.0M
0
1.340 B
2025
1.431 B
2026
1.528 B
2027
1.632 B
2028
1.743 B
2029
1.862 B
2030
1.989 B
2031
The market's trajectory is also shaped by the growing adoption of day-case thoracic surgery, bundled reimbursement models, and the integration of energy-based instruments into VATS workflows. Within the Type segment, forceps remain the largest revenue generator, representing approximately 34% of product revenue in 2025. The Hospital application dominates the Application segment, accounting for more than 70% of demand, while clinics and ambulatory surgical centers contribute emerging growth as payers push procedures to lower-cost settings.
Macro drivers include an aging population, persistent lung cancer incidence, and expanding computed tomography screening programs. The World Health Organization reports more than 2.4 million new lung cancer cases annually, and the proportion of early-stage diagnoses is rising as screening expands, directly supporting segmentectomy and lobectomy volumes. Simultaneously, the Minimally Invasive Surgery (MIS) Instruments Market is growing at a similar pace, creating a halo effect that supports VATS instrument adoption in institutions that did not previously operate dedicated thoracic surgery programs.
Despite positive fundamentals, the market faces countervailing pressures. Reusable instruments must comply with increasingly strict reprocessing standards, and the European Union Medical Device Regulation (MDR) transition has raised compliance costs for smaller vendors. Price negotiation by group purchasing organizations and publicly funded health agencies is also compressing margins, particularly in the mature North American and European segments. The Hospital Surgical Instruments Market continues to consolidate procurement, rewarding vendors that can demonstrate clinical outcomes and total cost of ownership rather than product features alone.
In this report, we quantify segment shares, regional growth corridors, and the competitive actions of leading vendors. The data support a cautiously optimistic outlook: the 6.8% CAGR will be led by Asia-Pacific, which is forecast to grow at a low-double-digit rate, while North America and Europe sustain steady but slower replacement demand. The strategic imperative for manufacturers is to balance reusable instrument quality with service-based single-use offerings that address infection control and reprocessing cost concerns.
Segment Deep-Dive: Forceps Dominance in Video-Assisted Thoracic Surgery (VATS) Instruments Market
Revenue Share and Growth Dynamic
Forceps are the most frequently used instrument type in VATS procedures, generating an estimated $0.46 billion in 2025 and capturing a 34% share of the Type segment. The Thoracic Forceps Market is expanding at a projected CAGR of 7.4%, outpacing the overall Thoracic Surgery Instruments Market, which is developing at 6.8%. Forceps perform multiple functions during thoracoscopy, including lung retraction, grasping, dissection, and biopsy. Their indispensable role in both wedge resections and anatomical lobectomies makes them a recurring purchase item for hospitals and surgical centers.
Within the Endoscopic Instruments Market, VATS forceps are under some substitution pressure from advanced bipolar and ultrasonic devices. However, the affordability and reusable nature of forceps keep them central in high-volume thoracic programs. The shift toward single-port VATS has increased demand for articulating and curved forceps, pushing manufacturers to invest in bendable shafts and enhanced jaw configurations.
Sub-Segment Breakdown: Reusable vs. Disposable
The Reusable VATS Instruments Market remains the larger of the two sub-segments, representing roughly 68% of forceps revenue in 2025. Hospitals with high procedure volumes prefer reusable forceps because of lower per-procedure instrument cost and established sterilization workflows. Nevertheless, the Disposable VATS Instruments Market is growing at a 9.1% CAGR as hospitals evaluate total cost of reprocessing, including labor, chemicals, sterilization validation, and the risk of instrument-associated infection. Single-use forceps now include fenestrated designs, insulated shafts, and integrated suction ports that reduce incremental cost differences.
Margin and Pricing Pressures
Forceps unit pricing is bifurcating. Premium reusable forceps list between $1,200 and $2,500 per instrument, while disposable equivalents range from $80 to $150 per unit. This wide price band creates opportunities for vendors to position value-added features such as tungsten carbide jaw inserts, ergonomic rotating handles, and color-coded tip sizes. Still, manufacturers of premium reusable forceps face margin pressure due to rising raw material costs and standardized procurement contracts. To protect margins, leading vendors are introducing instrument-tracking chips, predictive maintenance services, and refurbishment programs that align with circular economy requirements in Europe.
Primary Market Drivers & Growth Restraints in Video-Assisted Thoracic Surgery (VATS) Instruments Market
Growth Catalysts
Demand for VATS instruments is closely tied to lung cancer surgical volumes. According to GLOBOCAN, trachea, bronchus, and lung cancer was responsible for an estimated 2.5 million new cases in 2022. With low-dose CT screening expanding in the United States, Japan, and China, the number of early-stage lung resections suitable for VATS is increasing by 8% to 12% annually in leading thoracic departments. This directly expands the addressable base for forceps, staplers, and retractors in the broader Thoracoscopy Devices Market.
Another major catalyst is the shift in reimbursement toward minimally invasive procedures. In the United States, shorter hospital stays associated with VATS versus open thoracotomy reduce episode costs by roughly 20% to 30%, supporting hospital investment in dedicated VATS instrumentation. Additionally, the Hospital Surgical Instruments Market is seeing stable capital budgets for operating room upgrades, with many institutions allocating more than 15% of surgical capital expenditure to minimally invasive tools.
Growth Restraints
The principal restraint is the high regulatory burden for reusable medical devices that come into contact with tissue. In the European Union, the EU MDR transition has caused several smaller VATS instrument makers to discontinue legacy products because of costly clinical evaluation requirements. In the United States, FDA 510(k) clearance remains predictable but takes 9 to 18 months. These timelines limit the speed at which new VATS instruments enter the market.
Cost containment in public health systems also slows purchasing. Hospitals increasingly favor vendor-managed inventory and capitated instrument pricing, which compresses margins for high-quality reusable VATS instruments. The competitive threat from robotic-assisted thoracic surgery is an additional restraint, as some health systems prefer capital-intensive robotic platforms with disposable instruments, diverting budget away from conventional VATS instruments. Yet the operating cost of robotic systems remains roughly $3,500 per case, leaving conventional VATS instruments cost-competitive in most markets.
B.Braun: Offers a comprehensive portfolio of reusable VATS forceps, needle holders, and scissors under the Aesculap brand, with emphasis on surgical workflow integration and sterile supply efficiency.
Olympus: Combines flexible endoscopy and thoracoscopic visualization with a growing line of hand instruments, leveraging strong distribution in Asia-Pacific and Europe.
Karl Storz: Known for precision-engineered rigid instruments and optical systems, Karl Storz maintains a loyal base among thoracic surgeons seeking durable reusable instruments.
Medtronic: Integrates VATS instruments with advanced energy platforms, enabling hospitals to standardize on a single vendor for tissue sealing and dissection.
Richard Wolf: Focuses on minimally invasive instrument miniaturization and offers specialized thoracoscopic suction and dissection instruments.
Integra LifeSciences: Supplies single-use and reusable surgical instruments for thoracic procedures, with strength in infection prevention and surgical site safety.
Geister Medizintechnik: A German precision instrument manufacturer providing scissors, forceps, and needle holders for VATS and arthroscopic procedures.
August Reuchlen: Maintains a legacy portfolio of titanium and stainless steel thoracoscopic instruments, particularly for neurosurgical and thoracic microsurgery.
Teleflex: Distributes and manufactures surgical instruments with a broad thoracic surgery offering, including lung retractors and thoracoscopic access devices.
Tian Song: A Chinese manufacturer offering cost-competitive VATS instruments for emerging markets, with growing exports to Southeast Asia and Latin America.
Strategic Milestones & Recent Developments in Video-Assisted Thoracic Surgery (VATS) Instruments Market
March 2023: European thoracic surgery associations updated technical recommendations for reusable VATS instrument reprocessing, prompting vendors to publish validated cleaning protocols for complex articulated forceps.
September 2024: A leading US device manufacturer introduced a single-use articulating thoracoscopic dissector with a 5-mm shaft, responding to surgeon demand for single-port VATS ergonomics.
January 2025: Karl Storz expanded its thoracoscopy portfolio with an upgraded 4K camera system that integrates with existing VATS instruments, reinforcing its ecosystem position.
May 2025: B.Braun announced a partnership with a group purchasing organization to provide instrument tracking technology for reusable VATS devices across 600 hospitals in North America.
October 2025: A Japanese manufacturer entered the Disposable VATS Instruments Market by launching a fenestrated forceps line designed to reduce reprocessing burdens in high-throughput lung cancer screening programs.
Regional Market Analysis & Growth Corridors for Video-Assisted Thoracic Surgery (VATS) Instruments Market
North America is the most mature and largest regional market, accounting for approximately 38% of global VATS instrument revenue in 2025. The United States drives demand through high procedure volumes, robust insurance coverage, and the presence of major manufacturers. The Canadian market is smaller but benefits from provincial centralized procurement and harmonized regulatory pathways with the FDA. North America is projected to grow at a steady CAGR of 5.9% through 2034.
Europe holds a 28% revenue share, with Germany, France, and the United Kingdom leading VATS adoption. The EU MDR is the dominant regulatory force, raising compliance costs and causing some instrument rationalization. We estimate Europe's CAGR at 6.1%, supported by replacement demand for existing instruments and increasing use of hybrid operating rooms. Nordic countries and Benelux exhibit high VATS penetration, while Southern Europe remains influenced by public procurement constraints.
Asia-Pacific is the fastest-growing regional market, with a projected CAGR of 8.6%. China is the largest generator of demand, given its central role in the global Thoracoscopy Devices Market and expanding lung cancer screening initiatives. India is emerging as a high-growth market due to rising surgical volumes and local manufacturing incentives. Japan and South Korea are mature but continue to adopt advanced reusable VATS instruments.
South America, the Middle East, and Africa together account for the remaining 9% of revenue, with Latin America growing at about 6.4% and Africa at a smaller base. Brazil and Mexico lead in Latin America, but reimbursement gaps and infrastructure constraints limit adoption. The Middle East and Africa market is still in early stage, characterized by concentrated private hospitals in GCC countries and South Africa.
Investment, M&A & Funding Activity in Video-Assisted Thoracic Surgery (VATS) Instruments Market
Over the 2023-2025 period, investment activity in the VATS instrument market focused on single-use devices, digital instrument tracking, and platform-based surgical ecosystems. Private equity firms have shown interest in established reusable instrument manufacturers because of their recurring revenue and strong brand relationships with hospitals.
2023: Olympus invested in an AI-based instrument inspection startup, aiming to automate quality control in central sterile processing departments and reduce reprocessing errors.
2024: A US-based medical device company acquired a single-use thoracoscopic instrument developer for approximately $120 million, adding a disposable forceps and dissector line that complements its energy platform.
2025: Medtronic expanded its partnership with an Asia-Pacific distributor to co-market VATS access and closure products in China, targeting high-volume lung cancer screening centers.
2025: A private equity consortium acquired a European supplier of titanium VATS instruments, signaling continued appetite for niche players with regulatory-approved product registrations.
High-growth sub-segments attracting capital include disposable forceps, articulating needle holders, and smart-tray systems that embed RFID tags into instrument sets. Strategic acquirers look for products that reduce hospital reprocessing costs and work with existing endoscopic platforms.
Supply Chain & Raw Material Dynamics: Video-Assisted Thoracic Surgery (VATS) Instruments Market
The VATS instrument supply chain is concentrated upstream in specialty metal production and precision forging. Medical-grade stainless steel alloys such as 316L and 17-4PH, titanium (Ti-6Al-4V), and tungsten carbide are the primary raw materials for reusable instruments. The Stainless Steel Surgical Instruments Market is a direct input market; price movements in nickel and chromium create immediate gross margin impact for instrument OEMs. Between 2021 and 2023, medical-grade stainless steel prices rose by approximately 18%, with tungsten carbide prices increasing 22% due to supply constraints in China and rising energy costs.
Manufacturers also rely on engineered polymers, primarily PEEK and glass-filled polycarbonate, for disposable instrument handles and insulation. Polymer prices have remained relatively stable, increasing 3% to 4% annually, but potential supply chain disruption from petrochemical raw material shortages remains a risk. German and Japanese forgers produce a significant share of high-precision instrument blanks, while China and Taiwan provide low-cost semi-finished components. This geographic concentration creates vulnerability to trade policy changes, shipping disruptions, and geopolitical tensions.
The 2024 Red Sea transit restrictions extended lead times for European VATS instrument manufacturers by four to eight weeks, forcing OEMs to hold higher safety stock and qualify alternative sources in South Korea and Czechia. Raw material substitution towards titanium is accelerating in single-use devices, despite titanium being roughly three times the cost per kilogram of stainless steel, because of MRI compatibility and reduced imaging artifact. Overall, procurement teams are prioritizing supplier diversification and long-term metal supply agreements to manage cost volatility.
Video-Assisted Thoracic Surgery (VATS) Instruments Segmentation
1. Type
1.1. Forceps
1.2. Scissors
1.3. Clamps
1.4. Needle Holders
1.5. Other
2. Application
2.1. Hospital
2.2. Clinic
2.3. Other
Video-Assisted Thoracic Surgery (VATS) Instruments Segmentation By Geography
1. North America
1.1. United States
1.2. Canada
1.3. Mexico
2. South America
2.1. Brazil
2.2. Argentina
2.3. Rest of South America
3. Europe
3.1. United Kingdom
3.2. Germany
3.3. France
3.4. Italy
3.5. Spain
3.6. Russia
3.7. Benelux
3.8. Nordics
3.9. Rest of Europe
4. Middle East & Africa
4.1. Turkey
4.2. Israel
4.3. GCC
4.4. North Africa
4.5. South Africa
4.6. Rest of Middle East & Africa
5. Asia Pacific
5.1. China
5.2. India
5.3. Japan
5.4. South Korea
5.5. ASEAN
5.6. Oceania
5.7. Rest of Asia Pacific
Video-Assisted Thoracic Surgery (VATS) Instruments REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 6.8% from 2020-2034
Segmentation
By Type
Forceps
Scissors
Clamps
Needle Holders
Other
By Application
Hospital
Clinic
Other
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Rest of South America
Europe
United Kingdom
Germany
France
Italy
Spain
Russia
Benelux
Nordics
Rest of Europe
Middle East & Africa
Turkey
Israel
GCC
North Africa
South Africa
Rest of Middle East & Africa
Asia Pacific
China
India
Japan
South Korea
ASEAN
Oceania
Rest of Asia Pacific
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. SDI Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Type
5.1.1. Forceps
5.1.2. Scissors
5.1.3. Clamps
5.1.4. Needle Holders
5.1.5. Other
5.2. Market Analysis, Insights and Forecast - by Application
5.2.1. Hospital
5.2.2. Clinic
5.2.3. Other
5.3. Market Analysis, Insights and Forecast - by Region
5.3.1. North America
5.3.2. South America
5.3.3. Europe
5.3.4. Middle East & Africa
5.3.5. Asia Pacific
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Type
6.1.1. Forceps
6.1.2. Scissors
6.1.3. Clamps
6.1.4. Needle Holders
6.1.5. Other
6.2. Market Analysis, Insights and Forecast - by Application
6.2.1. Hospital
6.2.2. Clinic
6.2.3. Other
7. South America Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Type
7.1.1. Forceps
7.1.2. Scissors
7.1.3. Clamps
7.1.4. Needle Holders
7.1.5. Other
7.2. Market Analysis, Insights and Forecast - by Application
7.2.1. Hospital
7.2.2. Clinic
7.2.3. Other
8. Europe Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Type
8.1.1. Forceps
8.1.2. Scissors
8.1.3. Clamps
8.1.4. Needle Holders
8.1.5. Other
8.2. Market Analysis, Insights and Forecast - by Application
8.2.1. Hospital
8.2.2. Clinic
8.2.3. Other
9. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Type
9.1.1. Forceps
9.1.2. Scissors
9.1.3. Clamps
9.1.4. Needle Holders
9.1.5. Other
9.2. Market Analysis, Insights and Forecast - by Application
9.2.1. Hospital
9.2.2. Clinic
9.2.3. Other
10. Asia Pacific Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Type
10.1.1. Forceps
10.1.2. Scissors
10.1.3. Clamps
10.1.4. Needle Holders
10.1.5. Other
10.2. Market Analysis, Insights and Forecast - by Application
10.2.1. Hospital
10.2.2. Clinic
10.2.3. Other
11. Competitive Analysis
11.1. Company Profiles
11.1.1. B.Braun
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. Olympus
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Karl Storz
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. Medtronic
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. Richard Wolf
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Integra LifeSciences
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. Geister Medizintechnik
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. August Reuchlen
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. Teleflex
11.1.9.1. Company Overview
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. Tian Song
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
12. Research Methodology
List of Figures
Figure 1: Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Breakdown (billion, %) by Region 2026 & 2034
Figure 2: Video-Assisted Thoracic Surgery (VATS) Instruments Volume Breakdown (K, %) by Region 2026 & 2034
Figure 3: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Type 2026 & 2034
Figure 4: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Type 2026 & 2034
Figure 5: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Type 2026 & 2034
Figure 6: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Type 2026 & 2034
Figure 7: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Application 2026 & 2034
Figure 8: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Application 2026 & 2034
Figure 9: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Application 2026 & 2034
Figure 10: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Application 2026 & 2034
Figure 11: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Country 2026 & 2034
Figure 12: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Country 2026 & 2034
Figure 13: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Country 2026 & 2034
Figure 14: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Country 2026 & 2034
Figure 15: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Type 2026 & 2034
Figure 16: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Type 2026 & 2034
Figure 17: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Type 2026 & 2034
Figure 18: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Type 2026 & 2034
Figure 19: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Application 2026 & 2034
Figure 20: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Application 2026 & 2034
Figure 21: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Application 2026 & 2034
Figure 22: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Application 2026 & 2034
Figure 23: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Country 2026 & 2034
Figure 24: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Country 2026 & 2034
Figure 25: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Country 2026 & 2034
Figure 26: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Country 2026 & 2034
Figure 27: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Type 2026 & 2034
Figure 28: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Type 2026 & 2034
Figure 29: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Type 2026 & 2034
Figure 30: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Type 2026 & 2034
Figure 31: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Application 2026 & 2034
Figure 32: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Application 2026 & 2034
Figure 33: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Application 2026 & 2034
Figure 34: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Application 2026 & 2034
Figure 35: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Country 2026 & 2034
Figure 36: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Country 2026 & 2034
Figure 37: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Country 2026 & 2034
Figure 38: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Country 2026 & 2034
Figure 39: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Type 2026 & 2034
Figure 40: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Type 2026 & 2034
Figure 41: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Type 2026 & 2034
Figure 42: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Type 2026 & 2034
Figure 43: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Application 2026 & 2034
Figure 44: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Application 2026 & 2034
Figure 45: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Application 2026 & 2034
Figure 46: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Application 2026 & 2034
Figure 47: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Country 2026 & 2034
Figure 48: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Country 2026 & 2034
Figure 49: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Country 2026 & 2034
Figure 50: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Country 2026 & 2034
Figure 51: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Type 2026 & 2034
Figure 52: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Type 2026 & 2034
Figure 53: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Type 2026 & 2034
Figure 54: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Type 2026 & 2034
Figure 55: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Application 2026 & 2034
Figure 56: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Application 2026 & 2034
Figure 57: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Application 2026 & 2034
Figure 58: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Application 2026 & 2034
Figure 59: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion), by Country 2026 & 2034
Figure 60: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K), by Country 2026 & 2034
Figure 61: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue Share (%), by Country 2026 & 2034
Figure 62: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume Share (%), by Country 2026 & 2034
List of Tables
Table 1: Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 2: Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 3: Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 4: Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 5: Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Region 2020 & 2034
Table 6: Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Region 2020 & 2034
Table 7: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 8: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 9: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 10: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 11: North America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Country 2020 & 2034
Table 12: North America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Country 2020 & 2034
Table 13: United States Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 14: United States Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 15: Canada Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 16: Canada Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 17: Mexico Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 18: Mexico Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 19: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 20: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 21: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 22: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 23: South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Country 2020 & 2034
Table 24: South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Country 2020 & 2034
Table 25: Brazil Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 26: Brazil Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 27: Argentina Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 28: Argentina Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 29: Rest of South America Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 30: Rest of South America Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 31: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 32: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 33: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 34: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 35: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Country 2020 & 2034
Table 36: Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Country 2020 & 2034
Table 37: United Kingdom Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 38: United Kingdom Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 39: Germany Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 40: Germany Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 41: France Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 42: France Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 43: Italy Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 44: Italy Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 45: Spain Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 46: Spain Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 47: Russia Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 48: Russia Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 49: Benelux Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 50: Benelux Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 51: Nordics Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 52: Nordics Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 53: Rest of Europe Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 54: Rest of Europe Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 55: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 56: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 57: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 58: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 59: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Country 2020 & 2034
Table 60: Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Country 2020 & 2034
Table 61: Turkey Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 62: Turkey Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 63: Israel Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 64: Israel Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 65: GCC Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 66: GCC Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 67: North Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 68: North Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 69: South Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 70: South Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 71: Rest of Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 72: Rest of Middle East & Africa Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 73: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Type 2020 & 2034
Table 74: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Type 2020 & 2034
Table 75: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Application 2020 & 2034
Table 76: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Application 2020 & 2034
Table 77: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue billion Forecast, by Country 2020 & 2034
Table 78: Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume K Forecast, by Country 2020 & 2034
Table 79: China Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 80: China Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 81: India Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 82: India Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 83: Japan Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 84: Japan Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 85: South Korea Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 86: South Korea Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 87: ASEAN Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 88: ASEAN Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 89: Oceania Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 90: Oceania Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Table 91: Rest of Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Revenue (billion) Forecast, by Application 2020 & 2034
Table 92: Rest of Asia Pacific Video-Assisted Thoracic Surgery (VATS) Instruments Volume (K) Forecast, by Application 2020 & 2034
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
Primary research contributed 70-80% of the total intelligence in this study, with semi-structured interviews and structured surveys conducted with stakeholders across the VATS instrument value chain.
Company types interviewed included: VATS instrument OEMs, reusable instrument reprocessing and sterilization service providers, single-use thoracoscopic device manufacturers, raw material suppliers for 316L stainless steel and titanium forgings, and group purchasing organizations (GPOs).
Specific stakeholder job titles targeted during primary research included: Director of Thoracic Surgery, Surgical Instrument Procurement Manager, Medical Device R&D Engineer, Sterile Processing Department Manager, and VATS Product Line Manager.
Inputs were validated with clinicians associated with the Society of Thoracic Surgeons (STS) and the European Society of Thoracic Surgeons (ESTS).
Secondary research comprised 20-30% of the total research effort and leveraged public sources including the FDA database, National Institutes of Health (NIH) publications, and the Association for the Advancement of Medical Instrumentation (AAMI).
Standard financial and commercial databases used included Bloomberg, Factiva, Hoovers, and PitchBook.
Industry benchmarking was performed against ISO 13485, EU Medical Device Regulation, and World Health Organization (WHO) surgical volume datasets.
Demand Modeling & Market Estimation
A top-down approach was used to size the parent market and allocate revenue across type and application segments, using national procedure volumes, hospital bed counts, and per-procedure instrument consumption rates.
A bottom-up model aggregated demand from each country in the regional breakdown, using metrics such as VATS lobectomies per 100,000 population, average instrument cycle time in sterile processing, number of thoracic surgery operating rooms, and annual instrument replacement rates.
The two approaches were reconciled via multi-level data triangulation, with segment-level estimates validated against vendor revenue disclosures and procurement contract pricing.
Data Accuracy & Quality Check
The final dataset is estimated to be accurate within 85-90%, based on the consistency between primary interviews, secondary source citations, and econometric modeling.
Every report is updated to the date of purchase, and regional projections are revised when new official statistics or regulatory announcements are released.
Data quality checks included cross-referencing vendor claims with publicly available clinical efficacy studies and hospital tender documents.
Frequently Asked Questions
1. Which emerging technologies and substitutes could replace traditional VATS instruments?
Robotic-assisted thoracic surgery systems, including the da Vinci platform, are the most visible substitute, while single-port endoscopic approaches reduce instrument count. Single-use flexible thoracoscopes with integrated cameras are gaining share in outpatient settings. These alternatives will moderate growth of reusable VATS instruments but are unlikely to fully replace forceps and dissectors before 2030.
2. Which region is growing fastest in the VATS instruments market?
Asia-Pacific is the fastest-growing regional market with a projected CAGR of approximately 8.6%, driven by lung cancer screening programs in China and expanding thoracic surgery capacity in India. North America remains the largest revenue contributor with roughly 38% share, while Australia and Japan lead adoption of advanced thoracoscopic technologies.
3. What are the main entry barriers and competitive moats in this market?
High regulatory costs, including FDA 510(k) clearance and CE Mark certification, delay market entry by 12 to 24 months. Long-term contracts with group purchasing organizations and hospitals create switching costs for established vendors. Relationships with thoracic surgeons and reusable instrument reprocessing expertise form durable competitive moats.
4. What is the current market size and growth forecast for VATS instruments?
The Video-Assisted Thoracic Surgery (VATS) Instruments Market is valued at $1.34 billion in 2025 and is projected to reach $2.43 billion by 2034, growing at a 6.8% CAGR. Forceps represent the largest type segment, while North America maintains the highest regional share.
5. How are pricing trends and cost structures evolving in the VATS instruments market?
Prices for reusable VATS instruments increased by roughly 3.5% per year during 2023-2025 due to rising stainless steel and tungsten carbide costs. Disposable instrument pricing is under steady pressure, with single-use device prices declining roughly 2% annually because of hospital cost-containment initiatives. Value-based procurement contracts are shifting payment from per-unit pricing to procedure-based bundles.
6. What raw material sourcing and supply chain issues affect VATS instrument manufacturing?
Manufacturers rely heavily on 316L stainless steel, titanium, and tungsten carbide sourced from suppliers in Germany, Japan, and China. Price volatility for medical-grade stainless steel rose during 2021-2023, with chromium and nickel price swings exceeding 20%. Logistics disruptions in the Red Sea and pandemic-era shortages extended lead times for forged component suppliers by 4 to 8 weeks.
.jpg){kind=small}
-Instruments.png)
-Instruments.png)
-Instruments.png)